Here's a derivative strategy on Glenmark Pharma by HDFC Securities

Long build-up was seen in the Glenmark Futures yesterday

Bonds, Stock markets, Shares, Trading
Primary trend of Glenmark Pharma's stock is positive
Nandish Shah Mumbai
1 min read Last Updated : May 22 2020 | 8:12 AM IST
Buy Glenmark Future at Rs 349

Target: Rs 360

Stop loss: Rs 343

Lot Size: 1,400

Rationale:

-- Long build-up was seen in the Glenmark Futures yesterday where we have seen 3 per cent(Prov) rise in the Open Interest with price moving up by 1 per cent.
 

Also Read

-- Primary trend of the stock is positive where the stock price is trading above its 100 and 200-day SMA
 
-- The stock price has broken out on the daily chart yesterday to close at four-month high with higher volumes
 
-- RSI Oscillators is placed near 65 level on the daily chart Indicating bullish set up for the stock
 
-- Nifty Pharma Index has broken out on the daily chart indicating Pharma as a sector can continue to do well for the coming days
Disclaimer: Nandish Shah is a Technical & Derivative Analyst at HDFC Securities. Views are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MarketsMarket technicalsHDFC SecuritiesGlenmark Pharma

Next Story